UK markets closed

4D Molecular Therapeutics, Inc. (FDMT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
24.45+0.49 (+2.02%)
As of 11:53AM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8887
Avg. Estimate-0.71-0.74-2.99-3.36
Low estimate-0.81-0.85-3.29-4.55
High estimate-0.64-0.65-2.63-0.95
Year ago EPS-0.77-0.24-2.58-2.99
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts8785
Avg. Estimate1.44M690k5.63M7.26M
Low estimateN/AN/A30kN/A
High estimate7M3.3M21M16.9M
Year ago sales850k20.2M20.72M5.63M
Sales growth (year/est)69.40%-96.60%-72.80%29.00%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.81-0.59-0.74-0.74
Actual EPS-0.77-0.24-0.75-0.66
Difference0.040.35-0.010.08
Surprise %4.90%59.30%-1.40%10.80%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.71-0.74-2.99-3.36
7 days ago-0.71-0.74-2.99-3.36
30 days ago-0.75-0.78-3.06-3.4
60 days ago-0.73-0.76-3.07-3.4
90 days ago-0.73-0.76-3.06-3.44
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 daysN/AN/AN/AN/A
Up last 30 days4354
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesFDMTIndustrySector(s)S&P 500
Current qtr.7.80%N/AN/AN/A
Next qtr.-208.30%N/AN/AN/A
Current year-15.90%N/AN/AN/A
Next year-12.40%N/AN/AN/A
Next 5 years (per annum)-15.90%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A